Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome'.

Journal of neuromuscular diseases - 1 Jan 2021

Atalaia Antonio, Ben Yaou Rabah, Wahbi Karim, De Sandre-Giovannoli Annachiara, Vigouroux Corinne, Bonne Gisèle

Abstract excerpt

BACKGROUND: Variants in the LMNA gene, encoding lamins A/C, are responsible for a growing number of diseases, all of which complying with the definition of rare diseases. LMNA-related disorders have a varied phenotypic expression with more than 15 syndromes described, belonging to five phenotypic groups: Muscular Dystrophies, Neuropathies, Cardiomyopathies, Lipodystrophies and Progeroid Syndromes. Overlapping...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathies
Share to Lamin Type A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lipodystrophy

Share to Muscular Dystrophies

Share to Phenotype

Share to Rare Diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 33682723
DOI: 10.3233/JND-200596
PMCID: PMC8203247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Laminopathies' Treatments Systematic Review: A Contribution Towards a 'Treatabolome'.PMID 33682723Read ↗

"Laminopathies": a wide spectrum of human diseases.Semantic proximity Read ↗

Laminopathies and the long strange trip from basic cell biology to therapy.Semantic proximity Read ↗

The laminopathies: a clinical review.Semantic proximity Read ↗

Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a 'Treatabolome'.Semantic proximity Read ↗

Overlapping syndromes in laminopathies: a meta-analysis of the reported literature.Semantic proximity Read ↗

Advances in basic and clinical research in laminopathies.Semantic proximity Read ↗

Phenomics and lamins: from disease to therapy.Semantic proximity Read ↗

Advanced human iPSC-based modelling of <i>LMNA</i> -related congenital muscular dystrophy enables development of targeted genetic therapies for muscle laminopathiesSemantic proximity Read ↗

Lipodystrophic syndromes due to LMNA mutations: recent developments on biomolecular aspects, pathophysiological hypotheses and therapeutic perspectives.Semantic proximity Read ↗

Navigating Lipodystrophy: Insights from Laminopathies and Beyond.Semantic proximity Read ↗

Targeted Therapies for Leigh Syndrome: Systematic Review and Steps Towards a 'Treatabolome'.Semantic proximity Read ↗

Autosomal recessive Emery-Dreifuss muscular dystrophy caused by a novel mutation (R225Q) in the lamin A/C gene identified by exome sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.